• Lexaria sold Premier Wellness Science Co. exclusive rights to use its patented DehyraTECH(TM) in Japan in a variety of CBD products
• Valcon Medical A/S also signed an agreement with Lexaria to use its platform for medical cannabis applications in Europe
• AnodGen Bioceuticals received a pharmaceutical license to use the platform for manufacturing and distributing CBD API powders in Europe, Australia, and New Zealand

Lexaria Bioscience (NASDAQ: LEXX) kicked off the month by announcing an exclusive license to Premier Wellness Science Co. for the use of its patented DehydraTECH(TM) technology in Japan in a variety of CBD products. Announced on June 3, this license would cover oral or non-liquid products and can be used in topical, hair-care, lip-care, and cosmetics segments. Premier is a wholesale and retail marketer of cosmetics and health foods in Japan. It also provides information and consulting services to entities in the anti-aging, beauty, and health industries. In addition, Premier also offers market research, data collection, and analysis for its clients. The arrangement with Lexaria includes minimum payments of $4.5 million to be paid over the first five years of the deal to maintain exclusivity, with the first payments being made beginning September 1, 2022. On June 2, 2022, Lexaria announced having signed an agreement granting Valcon Medical A/S rights to use the DehydraTECH platform for medical cannabis applications in Europe. The products subject to this license were classified as non-registered medical products and authorized through country-level programs or EU Commission-registered cannabis products. Valcon plans to use this platform in bulk powders, solid oral dosage forms, powder-filled capsules, compressed tablets, pills, oral melts, and topical creams and lotions. This non-exclusive license will attract milestone fees from Valcon upon completing batch validation and marketing authorization application approvals. Valcon is a European CMO that is good manufacturing practice (“GMP”) certified. It is licensed in Denmark to manufacture medical cannabis and works with partners to provide contract processing and bulk extract services. On June 8, 2021, Lexaria announced having granted a pharmaceutical license for using its DehydraTECH platform to AnodGen Bioceuticals. AnodGen, a contract manufacturing organization (“CMO”), manufactures and distributes active pharmaceutical ingredients for the pharmaceutical industry by focusing on plant-based medicine. With Lexaria’s license, AnodGen will manufacture and distribute cannabidiol (“CBD”) active pharmaceutical ingredient (“API”) powders in Europe, Australia, and New Zealand. The license covers both pharmaceutical and medical product applications for psychoactive cannabinoids and medical applications for non-psychoactive cannabinoids. In addition, it can also be extended to third-party companies to use in their products. Lexaria is confident that with these newly awarded licenses and ongoing research in hypertension and nicotine, it is preparing for increased global utilization of its technology and for increased cashflows in its journey towards profitability. In an interview with Unboxing Biotech (https://ibn.fm/EOkaJ) Chris Bunka, Lexaria’s CEO, shared his optimism for the company. In addition, he highlighted the company’s progress and the strides it would make as time progresses. More specifically, he acknowledged the advancement made so far regarding DehydraTECH and potential hypertension treatment, along with the company tapping into the nicotine replacement therapy (“NRT”) market. Lexaria held its 2022 annual meeting on May 31, 2022. One of the key agendas in the meeting was the appointment of directors and an auditor for the current and future financial years. In the meeting represented by approximately half of all shareholders shares, all the nominated directors and auditor Davidson & Company LLP were approved. This would set the stage for Lexaria’s material partnerships that would define the month of June, as described in a recent Zacks report and interview covering Lexaria (https://ibn.fm/5UolH). Going forward, Lexaria looks to follow through with its clinical studies, advance its research and forge even more partnerships with other key players in the CBD space. In addition, the company looks to leverage its unique value proposition to grow its revenue and create value for its shareholders. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Meta Materials, an inventor, designer, developer, and manufacturer of sustainable, highly functional materials, recently entered into a definitive agreement to acquire substantially all the assets and intellectual property of Optodot Corporation
• The acquisition will expand Meta’s proprietary portfolio of battery materials with Optodot’s NPORE(R) separators that enhance thermal stability – and therefore battery safety – and electrochemical performance
• Lithium-ion batteries power all-electric vehicles but are linked to many problems, including but not limited to overheating and flammability, short life spans, and underperformance, and Optodot’s technology addresses these problems

Meta Materials (NASDAQ: MMAT) (FSE: MMAT), a global company that invents, designs, develops, and manufactures sustainable, highly functional materials that enable leading brands to deliver breakthrough products to their customers in consumer electronics, automotive, clean energy, aerospace, health and wellness, and 5G communications, recently expanded its capacity for innovation and product development even further with a strategic acquisition that targets the global lithium-ion battery separators market projected to reach $9.0 billion in 2025, which is up from $5.1 billion in 2021. Captured in a definitive agreement between itself and Optodot Corporation (“Optodot”), the acquisition will see Meta Materials purchase substantially all of the assets and intellectual property, including 67 issued and 22 pending patents. Under the terms of the agreement, Meta Materials will pay a total consideration of $48.5 million, comprising $3.5 million in cash and $45 million of MMAT shares of common stock. The transaction, which strengthens Meta’s portfolio of proprietary battery materials, is expected to close in June, subject to regulatory approvals and customary closing conditions. Given current projections and problems linked with the use of electric vehicles (“EV”), the acquisition could not have come at a better time. Consultants Ernst & Young, for instance, predict that electric vehicle sales in Europe, China, and the U.S, the world’s largest automotive markets, will outpace other engines sooner than initially anticipated. By 2045, the projections show, non-EV sales will have declined to less than 1% of overall sales (https://ibn.fm/WlOav). But as a 2021 Forbes article notes, consumers must be wary of battery safety before thinking of buying or driving off with an EV (https://ibn.fm/HKNKc). “Lithium-ion batteries power every electric vehicle on the road. But there are problems with these batteries: overheating and flammability, short life spans and underperformance, toxicity, and logistics challenges, such as proper disposal and transportation,” reads the Forbes article. Optodot understood these problems and has been developing technologies that address them: its NPORE(R) battery separators have undergone various iterations and improvements. The first generation separators commonly used today are made by coating a plastic substrate with ceramic material on one or both sides. The second-generation separators, known as NPORE(R) ceramic separators, utilize a flexible, free-standing ceramic nanoporous membrane separator for lithium-ion batteries, which does not contain a plastic substrate. They boast less than 1% heat shrinkage for better battery safety, 5x higher thermal conductivity than plastic separators, and flame resistance. They also have high electrochemical performance with superior abuse resistance (https://ibn.fm/yQS6l). Developed with funding by the Department of Energy (“DOE”), Optodot’s third-generation NPORE(R) Electrode Coated Separator (“ECS”) technology aims to improve energy and power density, battery longevity, and safety while reducing the cost of manufacturing lithium-ion batteries and the inactive components by 20-40%. The technology incorporates new inactive components and uses a simpler, faster battery assembly process. “Optodot has developed disruptive, high-performance ceramic nanomaterials in partnership with leading battery and medical equipment OEMs. Through this strategic acquisition, METAexpands its nanomaterials library and core expertise to address key challenges in battery safety and other applications, opening multi-billion-dollar markets,” said Meta Materials President and CEO George Palikaras. Over the last two decades, Optodot has been pioneering technologies that improve the safety of batteries in partnership with leading U.S. government agencies, innovative start-ups, and leading OEMs. So far, Optodot has worked with LG Chem and is a portfolio company of LG Technology Ventures. In addition, the company has collaborated with leading battery companies and global automotive OEMs. Following the definitive agreement with Meta Materials, Optodot is optimistic about the future. “Our complementary technologies and partnerships will help accelerate market adoption in EVs and other industries. We look forward to leveraging each firm’s combined expertise and technology and the benefits of scale and visibility, which META will bring to the Optodot platform,” commented Dr. Steve Carlson, President and CEO of Optodot. Through its PLASMAfusion(TM) technology, META creates thin coated copper current collectors that result in an 80% reduction in weight and inhibit thermal runaway. And, according to the company, Optodot products can be combined and coated with the technology. As global companies such as Amazon.com, Inc. (NASDAQ: AMZN) (which has committed to adding 100,000 EVs by 2040), Unilever (LON: ULVR) (which is working to electrify its fleet by 2030) and Walmart (NASDAQ: WMT) (which intends to convert its fleet to 100% EVs 2040) embrace EVs to drive their Environmental Social Governance (“ESG”) agendas, the existence of safer EV battery technologies will be a substantial boost to these efforts. For more information, visit the company’s website at www.MetaMaterial.com.

The 3rd Annual Cannabis Convention is being held in Burlington, Vermont on June 25-26, 2022, for the cannabis trading community in the area. Operating since 2014, NECANN events are one of the largest cannabis events that are constantly expanding. The NECANN events attract a huge number of members from the Hemp, MMJ and Cannabis industries.  The success and the ever-growing network base of the NECANN events are attributed to:

• the organizers who dedicatedly put together the event for the benefit of the cannabis trading communities
• the exhibitors who enrich the events with their new and innovative ideas and products
• the attendees who make these 2-day events such a huge success

Vermont became the 11th state to regulate adult-use cannabis sales, and the second state to do it through legislation rather than a voter initiative. Beginning in the fall of 2022, the cannabis retail market in Vermont is expected to start trading. The Vermont Cannabis Convention unites thought leaders of the industry who share their expertise and insights at the conference. The event will showcase, Atlas Seed, Setronics Corp., Omuerta Genetix, and many others. The exhibitors are putting up an excellent show of unique ideas and products such that attendees at NECANN Burlington get a fresh perspective on the cannabis industry. The convention offers a wonderful platform where influential members of the local community can come forward and help the budding cannabis community thrive. This will give the local cannabis trade a boost and traders will get a huge arena for exposure. Capital investors and eminent businesses looking for investing avenues can visit the conference. Many young entrepreneurs trying to carve a niche in this trade are waiting to get discovered! Some important topics to be discussed at the convention:

• Fundamentals of starting a cannabis business in Vermont
• The state of medical cannabis in Vermont
• Cannabis cultivation best practices
• Insurance for cannabis business
• Social equity in cannabis in Vermont
• Cannabis curriculum and education
• Cannabis extraction, and more

Participants above the age of 21 are eligible to attend the event. Hotel and exhibitor reservations are available for interested cannabis traders. To learn more, please visit https://necann.com/vermont/.

• Technology company SPYR recently completed the acquisition of mobile IoT technology company GeoTraq, Inc.
• GeoTraq develops state-of-the-art mobile IoT modules, specifically designed to fit the unique and unmet needs of the low-end IoT market
• Major players have focused on developing and selling complex and expensive high-end IoT systems, with little attention paid to the larger low-end market
• GeoTraq is targeting this underserved segment through uniquely-engineered products that are battery-compatible and easy to deploy

This year, the global location-based services (“LBS”) market is expected to reach a value of $70.16 billion, representing a CAGR of 25.5% from $55.92 billion last year. Projections further show that the market will expand by an additional 15.5% CAGR, reaching $114.9 billion by 2026 (https://ibn.fm/PV9tI). The Report Linker analysis, however, mainly highlights major players, including but not limited to Apple Inc. (NASDAQ: AAPL), Cisco Systems, Inc. (NASDAQ: CSCO), Intel Corporation (NASDAQ: INTC), Microsoft Corporation (NASDAQ: MSFT), saying little of the role smaller players will play. But GeoTraq, Inc., a mobile Internet of Things (“IoT”) technology company, and now a second subsidiary of SPYR (OTCQB: SPYR), is looking to change this narrative, having identified a large and untapped opportunity. Guided by the vision to create a simple, smart, and connected world, GeoTraq designs and develops self-contained, fully integrated, mobile IoT modules targeting a less crowded but fundamental niche that the major players largely ignore as they target the complex and costlier needs of higher-end segments of the LBS market. Buoyed by unmatched financial muscle, tech behemoths often focus on the same type of high-end products and target markets, involving elaborate software, hardware, and platforms, all involving expensive engineering support due to a heightened level of complexity. These solutions are designed around a lot of bandwidth and traffic, with myriad sensors, 4G/5G modules, and a larger size. The various high-tech components of such systems require plenty of power and are, therefore, mostly used in stationary applications such as high-speed large-scale operations that involve continuous high-volume tracking and communication. However, for things like mobile applications and lower-volume requirements, these power-hungry high-tech solutions represent a problem due to their unavoidable drain on any type of battery support. Having established that there is a big market for compact and low-power battery compatible LBS solutions, GeoTraq began developing mobile IoT modules packaged in a form factor so small that it fits almost anywhere, tapping into any available outside battery source or its own internal battery. In fact, according to GeoTraq’s website (https://ibn.fm/bGNTU), stand-alone modules are equipped with a 10+ year supply of battery life attributable to the implementation of a deep sleep state that ensures the product is in the rest mode 99% of the time, only activating to periodically monitor and send crucial location-based data as needed. GeoTraq’s state-of-the-art engineering means modules that are plug-and-play and are capable of deployment in less than five minutes. In contrast, according to GeoTraq, the average high-end IoT deployment can take close to a year, requiring a handful of vendors as well as multiple complex components. GeoTraq’s plug-and-play attribute, coupled with their small form factor, makes the modules ideal for integrating into a variety of objects that a company may want to track, such as electric drills, mobile toilets, guns, and shipping containers, just to mention a few, adding easy and cost-effective intelligent asset tracking and remote monitoring capabilities. “GeoTraq addresses the large LBS market segment that is currently underserved with existing solutions due to high deployment costs (hardware, service, logistics), limited battery life, and large form factor. We believe there is a large, underserved portion of the LBS market that is not addressed by existing solutions. RFID and Wi-Fi require proximity for asset tracking, while GPS is too bulky and uses too much power for many needs. GeoTraq addresses the white space in-between by designing wireless transceiver modules with technology that provides LBS directly from global mobile IoT networks,” commented GeoTraq Project Engineer Chris Chammas in a recent news release announcing the outcome of a patent application (https://ibn.fm/83p4f). GeoTraq has already identified two existing markets for its unique low-power mobile IoT modules: the retrofit market and the disposable market. The former involves use cases involving tracking of battery-powered equipment that has space to fit the module and an antenna. The latter encompasses applications that do not have a battery, allowing the module to use its own small disposable battery. In addition to the hardware, GeoTraq also develops WebTraq, a backend platform that lets users activate and manage GeoTraq-enabled devices. WebTraq also boasts API integration with other IoT platforms or legacy systems, ensuring convenience, versatility, and seamless reporting (https://ibn.fm/npI0R). GeoTraq is actively involved in protecting its valuable intellectual property. In a recent announcement, SPYR reported that its subsidiary had been granted a patent (Patent No. 10,182,402) that covers various aspects of the operation of the GeoTraq mobile IoT wireless modules. For more information, visit the company’s website at www.Spyr.com. NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

• CEO notes that company will be well-positioned moving forward, “especially as our large Lemon Glow property comes online.”
• Short term, Sugarmade is embarking on a bold, new strategy to enter into contract arrangements with local Lake County, California, cultivators.
• SGMD is already in negotiations with local permitted and licensed operators that are agreeable to partnership arrangements for cannabis cultivation.

The evolving California cannabis market is creating promising long-term and short-term opportunities for Sugarmade (OTC: SGMD) — and its shareholders. That is the message in a shareholder letter from CEO Jimmy Chan that was sent to all SGMD shareholders (https://ibn.fm/mQzfS). “While there is undoubtedly short-term turbulence in the market, we believe the long-term outlook of the cannabis industry is very bright, especially for California producers and distributors,” Chan stated in the letter. “Historically, California-grown cannabis has always been highly desirable in the marketplace. Sugarmade believes this will continue as legalization at the U.S. federal level creates substantial opportunities to supply other states with top-grade California-grown cannabis. Thus, we expect our company will continue to be well-positioned moving forward, especially as our large Lemon Glow property comes online.” Sugarmade closed on the acquisition of Lemon Glow Company Inc. and all of its assets, interests, property, and rights last year (https://ibn.fm/XKJHb). The acquisition included 640 acres of property, of which 32 acres have already been designated for outdoor cannabis cultivation. At full scale production, the company estimates the annual potential cultivation yield of the property to be some 4,000 pounds of dry trimmed cannabis flower per acre per year, which represents approximately 128,000 pounds, or 64 tons, of dry trimmed cannabis flower per year in total. Short term, the letter outlines several strategic opportunities that the company intends to pursue. Noting several significant changes in the marketplace, including an uncertain regulatory environment, high taxes, and drop in prices for cultivated cannabis products, Chan observed that numerous cannabis cultivation license holders, including unlicensed growers, have been forced to forgo plans to directly cultivate cannabis this year. Calling this an “opportunity to invoke a new short-term strategy while our long-term plans to cultivate at our new Lemon Glow facility are developing,” Chan explained that for the 2022 cannabis cultivation season, Sugarmade is “embarking on a new and bold strategy to enter into contract cultivation arrangements with local Lake County, California, cultivators that have decided not to engage in their own cultivation efforts for the 2022 season. “These operators have already made significant investments in infrastructure and have highly specialized personnel available that we can utilize on a contract basis for our production of cannabis,” the letter stated. “By contracting with the owners of these already available resources, Sugarmade will gain immediate access to the marketplace based on an advantageous cost model that will place Sugarmade on par, or in some cases, at a superior cost position compared to many of the larger cannabis cultivation and distribution companies in the industry.” Chan reported that the company is already in negotiations with several local permitted and licensed operators that are agreeable to a partnership arrangement with Sugarmade to manage operations for cannabis cultivation. “We are also in active negotiations on the distribution side of the business that will allow Sugarmade to bring this cultivated cannabis to the marketplace,” he continued. “Invoking this dynamic short-term strategy, while continuing to develop our longer-term strategy to fully develop the large Lemon Glow property for cultivation, will allow Sugarmade to significantly advance the timeframe for gaining market share in this industry, and we believe we will be able to do so based on a cost model that will allow us to produce strong margins this cultivation season.” For more information, visit the company’s website at www.Sugarmade.com. NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SGMD

• FingerMotion just announced a 37% annual revenue growth from $6.24 million in 2021 to $22.93 million for the 2022 financial year
• Big Data posted the most significant growth at 297%, followed by Telecommunications Products & Services at 170% and SMS & MMS at 5%
• The company looks to keep pushing gross margins higher by leveraging the optimization of its product offerings

FingerMotion (NASDAQ: FNGR) just released its financial results for the year ended February 28, 2022, which was an incredible year for the company. Annual revenue rose from $6.24 million in 2021 to $22.93 million in 2022, representing a 37% growth. This maintains the company’s upward trajectory, having posted an 82% revenue growth from FY 2020 (https://ibn.fm/J3Suj). During the release of the FY 2021 financial results, Martin Shen, FingerMotion’s Chief Executive Officer (“CEO”), noted that the company’s biggest challenge at the time was access to non-dilutive capital. However, he maintained his optimism that the company would reach profitability soon. “We have been able to steadily increase our margins by optimizing our product mix between Top-up and SMS,” he noted. “While our biggest challenge continues to be access to non-dilutive capital, we remain steadfast in our belief that we will reach profitability in the near future,” he added (https://ibn.fm/aCNhp). For the FY 2022, FingerMotion inched closer to achieving this goal, having posted gross profits of $2.81 million, representing a 71% increase from the previous year. This was mainly achieved through the growth of the SMS & MMS business, which posted a 5% year-over-year (“YOY”) growth, as well as Telecommunications Products and Services, which posted a 170% revenue growth from 2021. However, the sector that posted the highest growth was Big Data. Revenue for this sector grew by 297% from the previous year, carrying on the momentum initiated in 2021. When releasing the FY 2021 results, Mr. Shen was keen to note that Big Data showed incredible potential for growth. As such, he projected that by the end of the 2021 calendar year, the company will have closed multiple contracts relating to its Insurtech products, ultimately allowing for the growth of this sector. “The company is rapidly evolving, and we saw the first indication of revenue, albeit small, from the Big Data Insights division and from our new venture selling subscriptions and mobile phones,” noted Mr. Shen. “We are a technology company and believe our future lies in the Big Data Insights division,” he added. The annual cost of revenue for the 2022 financial year stood at $20.11 million, up from $5.08 million in 2021. The annual net loss was $4.94 million, up from $0.56 million in 2021. As of the close of the financial year, FingerMotion had $461,993 in cash and cash equivalents, a working capital surplus of $4.93 million, and a positive shareholders’ equity of $5.09 million. Total assets for the company were $10.37 million, with total current liabilities at $5.28 million. Lastly, 42,627,260 common shares were issued and outstanding as of the close of the 2022 financial year. In addition to growth in financial performance, Mr. Shen also acknowledged the company’s NASDAQ uplisting as a critical milestone. He also noted that the company achieved over $5.0 million in shareholders’ equity, another significant milestone. Going forward, Mr. Shen noted that the company will keep pushing gross margins higher, which will be influenced by the optimization of the company’s product offerings. In addition, FingerMotion plans to follow through with its mobile protection program, whose rollout is on schedule, which, it is confident, will play an integral role in the company’s growth for the current financial year. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Flora’s collaboration with Highsman seeks to elevate both Highsman and Vessel, Flora’s accessories brand, thereby inspiring greatness and creating an experience worth sharing
• The company’s acquisition of Masaya allows it to deliver on its promise to invest in safe, thorough, and cutting-edge cannabis researchws
• Flora’s product launch on Amazon.co.uk marks a big step in operations expansion in Europe

The first half of 2022 has been successful for Flora Growth (NASDAQ: FLGC). At the beginning of the year, the company’s management noted how the cannabis sector was ripe for the picking. They noted how great brands and cost advantages are optimal traits for the company’s long-term market leadership and return on investment (“ROI”), emphasizing the opportunities ahead (https://ibn.fm/YlHId). Flora Growth has since partnered with Highsman, a cannabis lifestyle brand built on an appreciation for greatness, founded by former NFL running back Ricky Williams. The collaboration seeks to elevate Highsman and Flora’s cannabis accessories brand, Vessel, (https://ibn.fm/FmwMg). While announcing the collaboration, James Choe, Flora Growth Chief Strategy Officer (“CSO”) and President of Vessel noted that “Ricky’s story personifies the authenticity and individuality that exists at the core of Vessel, and this collaboration is a true representation of the freedom to be original.” Following the announcement of the Ricky Williams collaboration, flora announced the acquisition of CBD Brand Masaya. Flora entered into an agreement with Dr. Annabelle Manalo-Morgan, a leading cell biologist, to acquire her brand, along with its patent-pending CBD formulations, which are made up of potent CBD oil and are 100% THC-free (https://ibn.fm/cO4uF). Upon acquisition, Masaya became an owned Flora brand sold in the United States and the first offering from Flora Life Sciences. It is also projected that the patent-pending formulation, Masaya Pure, will be used in Flora’s current clinical trials with the University of Manchester in the UK. The doctor now serves on Flora’s Board of Directors as the company’s Scientific Advisor. She is also responsible for leading Flora’s global research initiatives, including the ongoing clinical trial on the use of cannabinoids with patients with fibromyalgia. “We are excited to announce the acquisition of Masaya. The brand’s formulation was developed by Dr. Annabelle for her son and has since been used by thousands of consumers,” noted Luis Merchan, Flora’s Chairman and Chief Executive Officer (“CEO”). “This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for the people worldwide,” he added. At the close of May, Flora announced that its wholly-owned subsidiary, JustCBD, would be launching its line of Novel Foods registered CBD products on Amazon.co.uk. Set to launch on the e-commerce store in June 2022, this move would see customers in the UK access JustCBD’s best-selling gummies and tinctures (https://ibn.fm/goRlL). This launch marked a significant step in Flora’s operations expansion in Europe. In addition, it showed the company’s commitment to delivering quality cannabis-related products to customers aiming to improve their health and wellness. “With health and wellness playing an increasingly important role in customers’ lives, we are excited to increase the selection of quality CBD products offered to Amazon customers in the UK,” noted Hussein Rakine, JustCBD’s CEO. “The JustCBD team looks forward to working closely with Amazon to expand our product offering to other countries as our partnership and brand presence in the United Kingdom grows,” he added. Going into the second half of the 2022 calendar year, Flora Growth seeks to aggressively pursue the goals set at the beginning of the year, further expanding its market reach and growing its product line and customer numbers. For more information, visit the company’s website at www.FloraGrowth.com. NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

Professionals and executives from the pharma, biotech and medical device companies are invited to attend the virtual online streaming Transparency and Aggregate Spend Summit organized by DGE. The virtual summit is hosted by DGE (Dynamic Global Events), a life science leader in organizing B2B events for the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.  The virtual summit offers a wonderful opportunity for professionals in the life sciences industry to understand the requirements and caveats of Open Payments reporting, as well as know the state-to-state regulations for HCP spend reporting. Attendees can get the latest information on the guidelines and timelines for global transparency, as well. Thought leaders will share insights and knowledge about the tools you need in order to ensure complete and accurate data and identify compliance risks. They will further share tips for managing high-risk HCP interactions, data integrity, and sharing compliance intelligence. This virtual platform offers a phenomenal learning opportunity on the aspects of compliant HCP spend reporting. Agenda of the summit:

• Learn the needs and regulations of Open Payments reporting
• Understand the state-to-state regulations for HCP spend reporting
• Get acquainted with the guidelines and timelines for global transparency
• Understand the intricacies of auditing previous years’ reporting to identify gaps and improve efficiency for the future
• Improve your transparency program for cost-savings

The team of life science event professionals at DGE specializes in providing a conducive networking environment where attendees can be a part of the summit from within the comfort of their homes or workspaces. To learn more, please visit https://ibn.fm/FeHbk.

Virtual Event – June 23, 2022 Maxim Group LLC is presenting M-Vest Events, Digital Assets Conference on Crypto Assets and Metaverse. Moderated by the Maxim Group Research Analysts, the event will witness top-ranking executives from private and public companies, with panel discussions on important topics in this spectrum. A division of Maxim Group LLC (“Maxim Group”), M-Vest offers a platform that offers investment opportunities online to investors and also provides a digital community for issuers, investors, and thought leaders to exchange ideas. The forum provides insights on current market trends through presentations from innovative emerging growth companies, redefining the traditional concepts of investment banking. Important topics of panel discussions at the M-Vest Events include:

• How the rising rates influence the value of bitcoin, NFTs, and other digital assets
• Future market opportunities and development around collectables and gaming
• Emerging regulation around crypto-assets and trading
• The application of NFTs and the metaverse to personal identity

Distinguished industry veterans will be making their presence felt at the virtual event. They will offer their valuable insights on current market trends and emerging companies will hold presentations for better visibility of their products. Attendees can interact with the thought leaders via live events and Q&A. Capital raisings provide an opportunity for our investor community to participate in Regulation A and Regulation D offerings. Emerging companies and budding entrepreneurs from the metaverse, gaming, mining, NFTs, and similar platforms will exhibit their products, ideas, and innovations. Those attending this Digital Assets Conference will have exposure to the latest launches and the future trends of the industry, much ahead of their competitors. Investors and capitalists in search of lucrative investments can explore their options on this floor. The dedicated team of professionals at M-Vest is led by Cliff Teller, Executive Managing Director, Head, M-Vest. They have created M-Vest with a vision to offer valuable information and foster communication and networking between companies, industry leaders, executive managers, and investors globally. Maxim Group LLC is a leading full-service investment bank, securities and wealth management firm headquartered in mid-town Manhattan. The M-Vest Digital Assets Event will host virtual sessions where thought leaders and executives will share insights on the future trends of crypto and Metaverse. Eminent industry heads and global brands will be attending the event to participate in discussions and fireside chats. Budding companies, enthusiasts and gamers can leverage this phenomenal platform to showcase their skills and get discovered by investors. To learn more, please visit https://ibn.fm/tN8WV.

• Eat Well completed the acquisition of Belle Pulses, Sapientia, and Amara Organic Foods within the 2021 financial year, producing a 1,082% asset growth over that period
• In addition to raising over $33 million of debt, the company also bolstered its Board of Directors and advisory board
• Eat Well is confident that with the foundation laid down so far, it’s portfolio companies will achieve revenues of between $90 million and $110 million in 2022, with bottom-line profitability and combined investments growing throughout the year

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) just released its financial reports for the fourth quarter and the entire year of 2021. When making the announcement, Marc Aneed, the company’s Director, President, and Chief Executive Officer (“CEO”), noted that over the course of the 2021 financial year, the company laid a strong foundation, positioning its portfolio companies to capture global pulse demand, and satisfy consumer needs (https://ibn.fm/t1KAY). “We have laid a strong foundation within the Eat Well Group investment platform, and we are very enthusiastic about the trajectory of our portfolio,” noted Mr. Aneed. “The global plant-based foods market continues to rapidly expand as consumers make healthier decisions for themselves and their families. Our portfolio companies are well-positioned to capture global pulse demand and accelerate the scale of their better-for-you consumer products for years to come,” he added. Over the 2021 financial year, Eat Well made significant acquisitions to strengthen its platform. It acquired all outstanding Belle Pulses Ltd. and Sapientia Technologies, LLC shares. The company also acquired a 51% majority equity interest in Amara Organic Foods, ultimately growing its assets from $5,043,430 in 2020 to $59,627,414 in 2021, representing a 1,082% growth. Under Eat Well’s ownership, Sapientia launched its first white-labeled protein twist with Federated CO-OP stores in western Canada. The products were stocked on shelves across 350 stores as of December 2021. In addition, these protein twists were recognized as a Finalist in the Canadian Grand Prix New Product Awards. Together, Eat Well’s three acquisitions generated positive net earnings of $1,478,420 despite the challenges posed by Covid-19 restrictions and a global supply chain crisis. Amara Organic Foods, owned by Pata Foods, achieved a 320% growth in revenue for the 2021 financial year, mainly influenced by the launch of its “toddler melts” product across North American retail. Over the 2021 financial year, Eat Well also raised $33.5 million of debt from a leading Canadian institution and went ahead to complete two subsequent event equity financings of $5.1 million and $5.018 million each. It also made key appointments to its Board of Directors while expanding its senior management team with additional expertise in plant-based foods investing, consumer packaged goods investing, strong governance, and over 150 years of collective experience. For the 2022 financial year, Belle Pulses projects an improved margin performance due to normalizing supply chains and improvement with Covid-19-related restrictions. In addition, strong global demand, driven by the Russia/Ukraine conflict disrupting pulse supply overseas, will also be another contributing factor. On the other hand, Amara will continue expanding its reach to new consumers. It ended the 2021 financial year with approximately 6,000 total distribution points across North American retail, having closed distribution deals with Walmart Canada, Sobeys, HEB, Loblaws, and more. With the foundation Eat Well Investment Group has laid down so far, the company is well-positioned to take its fundamental propositions to the next level. It is also well equipped to continue fueling the world’s plant-based consumption needs while raising its portfolio investments’ drive capacity, scale, innovation, distribution, and fiscal discipline. To that effect, Eat Well maintains that its revenue guidance for its investee companies stands at $90 million to $110 million for the 2022 financial year, with bottom-line profitability of combined investments projected to improve throughout the calendar year. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF